This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of California. Active years: 1997-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Carlos, CA (US) (1997 - 2007)
- Pacifica, CA (US) (2014 - 2016)
Company Filing History:
Years Active: 1997-2016
Title: Innovations of Rajvir Dahiya
Introduction
Rajvir Dahiya is a prominent inventor based in Pacifica, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of small activating RNA molecules. With a total of 5 patents, his work has the potential to impact gene expression and therapeutic applications.
Latest Patents
One of Rajvir Dahiya's latest patents focuses on small activating RNA molecules and methods of use. This invention provides compositions, pharmaceutical preparations, kits, and methods for increasing the expression of a gene product in a cell. The method involves contacting the cell with a small activating RNA (saRNA) molecule that comprises a ribonucleic strand complementary to a non-coding nucleic acid sequence of the gene. This innovative approach could lead to advancements in gene therapy and molecular biology.
Career Highlights
Rajvir Dahiya is affiliated with the University of California, where he conducts research and develops his inventions. His academic background and research experience have positioned him as a key figure in his field. His work is characterized by a commitment to advancing scientific knowledge and practical applications in biotechnology.
Collaborations
Rajvir has collaborated with notable colleagues, including Emil A Tanagho and Tom F Lue. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Rajvir Dahiya's contributions to the field of biotechnology through his patents on small activating RNA molecules demonstrate his innovative spirit and dedication to advancing science. His work continues to pave the way for future developments in gene expression and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
